Thank you to the South Australian Government, BioSA and all our Event Supporters, Speakers, Exhibitors and Delegates who participated to make AusBiotech 2011 a conference to remember in South Australia.
AusBiotech 2011 national conference, with its theme Creativity, Capability & Capital was held in Adelaide, South Australia 16 - 19 October 2011. The annual event has earned a reputation as the industry’s premier biotechnology conference for the Asia Pacific region and now in its 10th year has proved its relevance to the Australian and international biotechnology industries, attracting more than 1100 participants including 233 international participants from 20 countries.
The national conference culminated with the Australasian Life Sciences Investment Summit which attracted over 180 participants and over 120 investors to view a showcase of selected Australian biotechnology companies.
AusBiotech was pleased to provide an added benefit for National Conference Delegates with a first ever entre to the Summit Gallery to listen to these valuable presentations
With so much to look forward to as our sector continues to go from strength to strength, we look forward to seeing you in Melbourne Victoria 2012. For expressions of interest in Partnership and Exhibition opportunities please contact Misha Prusa on firstname.lastname@example.org
Future Event Dates:
AusBiotech 2012 30 October - 2 November Melbourne Convention & Exhibition Centre
AusBiotech 2013 29 October - 1 November Brisbane Convention & Exhibition Centre
AusBiotech 2014 28 October - 31 October Gold Coast Convention & Exhibition Centre
More about the 2011 Conference Theme
A successful biotechnology industry needs a chain of three vital elements that are key in its ability to grow and be sustainable: Creativity, Capability & Capital.
Creativity is at the heart of the new ideas and innovation that begins in our research institutes and universities and continues into trials and commercialisation as companies mature and grow.
Capability is key to implementation in biotechnological innovation, where skills and know-how is the vehicle that drives new products and ideas through trials, regulatory approval and to the markets they will serve. Aside from knowledge in the life sciences, the industry thrives on business skills, the ability to do deals, and to market and sell products.
Capital is the ‘life blood’ of the biotechnology industry and access to it dictates the time to market. Reducing the time it takes to get biotechnologies to those who need them means faster revenues, enabling the chain to continue…